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Abstract   
 
Background: Chronic disease conditions like cancer, diabetes, malnutrition and HIV/AIDS compromise the immune 
system thus necessitating immune boasting. The use of medicinal herbs in immunomodulation is now common, albeit with 
limited evidence regarding efficacy. We therefore investigated the immunomodulatory activity of the total crude leaf and 
stem extract of Chenopodium opulifolium in mice.  
Materials and methods: An experimental study was conducted using four groups of rats each with 6 animals with 
treatments administered daily for 29 days.  Group one served as the positive control and received 20mg/kg of levamisole. 
Group 2, the negative control received 2 ml of an olive oil and normal saline mixture. Groups 3 and 4 received 100mg/kg 
and 200mg/kg bwt of the total crude leaf and stem extract respectively. On the 15
th 
day, whole blood was collected for 
complete blood count and delayed type hypersensitivity response determination, haemagglutination antibody titer assay was 
done on blood collected on the 29
th
 day.  
Results: Results revealed that the extract had a significant (P< 0.05) effect on haemagglutination antibody titers with the 
highest response observed in the extract group at 200mg/kg (30.67±1.33). The mean WBC (3.13±0.71×10
3
/µl), neutrophil 
(0.93±0.48
 
cells/ µl) and lymphocyte (2.20±0.00 cells/ µl) counts in the 200mg/kg bwt extract group were elevated to levels 
comparable to the positive control.   
Conclusion: The total crude extract of Chenopodium opulifolium exhibits immunomodulatory activity in a dose dependent 
manner. Future studies utilizing pure extracts in order to pin point to the extract mechanism responsible for 
Immunomodulation are required for more conclusive results.  
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Complete Blood Count, DTH: Delayed Type Hypersensitivity, HA: Haemagglutination Antibody, RBS: Red Blood Cells, 
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Introduction 
 
Communicable and non-communicable diseases remain a big global threat especially in developing countries due 
to their demographic and socio-economic constraints (Lim et al., 2012). In sub-Saharan Africa, disease burden is still 
dominated by communicable, maternal, neonatal, and nutritional disorders (Murray et al., 2012). Indeed, global mortality 
due to non-communicable diseases is projected to raise from 59% in 2002 to 69% in 2030 and HIV/AIDS deaths from 2.8 
million in 2002 to 6.5 million in 2030 (Mathers et al., 2006). The use of immunomodulatory drugs in enhancing host  
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defense is now an acceptable alternative in the management of disease (Singh et al., 2016) and involves both 
immunostimulation and immunosuppression (Patwardhan et al., 1990).  
Globally disease conditions are commonly managed by either conventional medicine or medicinal herbs. Although 
modern medicines are available, herbal remedies have often maintained popularity for historical and cultural reasons (Syed 
et al., 1996). Medicinal herbs used for immunostimulation can provide potential alternatives to conventional 
chemotherapeutics for a variety of diseases.  A variety of plant derivatives such as polysaccharides, lectins, peptides, 
flavonoids and tannins have been reported to modulate the immune system in various in vivo models (Venkatachalam et al., 
2009). In a study by Benencia et al. (1995), the aqueous leaf extracts of Cedrela tubiflora, a plant used in the treatment of 
inflammatory infections, was found to exert in vitro inhibition of some components of the human immune system related to 
inflammatory response. In a study by Gautam et al. (2009), the aqueous root extract of Asparagus racemosus was 
associated with T cell activation through an up regulation of CD3
+
 and CD4
+
/ CD8
+
 cell populations in addition to its high 
antibody titers and delayed type hypersensitivity response. In another study, the ethanolic seed extract of Caesalpinia 
bonducella was associated with an increase phagocyte activation and delayed type hypersensitivity reaction induced by 
sheep red blood cells (Shukla et al., 2009).  
Many species of Chenopodium are being used traditionally in the treatment of numerous ailments. Infusions made 
from the leaves and seeds of C. ambrosioides Linn have been proposed as a remedy against intestinal parasites and 
pulmonary obstruction (Yadav et al., 2007). Similarly, C. botrys Linn is proposed to be effective against asthma (Yadav et 
al., 2007).  In Uganda, Chenopodium opulifolium is currently recommended by traditional herbalists as an immune booster 
especially among individuals with HIV/AIDS. However, despite its usage, its efficacy as an immunomodulatory alternative 
has not been scientifically evaluated.  In this study, we investigated the immunomodulatory activity of Chenopodium 
opulifolium total crude extract using Wister albino rats. Results from this study will guide future pharmacological and 
toxicology studies about Chenopodium opulifolium. 
 
Materials and methods 
Plant material extraction and solvent recovery 
 
Fresh mature leaves and stem of Chenopodium opulifolium were collected from Makerere University herbarium 
(00° 20` 10˝N, 32° 33` 57˝E) and authenticated at the Herbarium unit with a voucher number (01, TJ) deposited for future 
reference. The leaves and stem were washed with clean water to remove dirt and soil before being dried in a solar drier until 
constant weight was obtained. The dried plant material were pounded using a motor and pestle into course powder to 
facilitate the extraction process.  About 500g of the course powder of Chenopodium opulifolium was poured in a plastic 
container and soaked in 1500mls of ether solvent for 72 hours with occasional agitation to facilitate the extraction process 
as previously described (Doughari, 2012). The mixture was then filtered with Whatman No.1 filter paper using a Buchner 
funnel and a suction pump (Sigma-Aldrich, USA). The filtrate was collected and the residue air dried overnight. Upon 
drying, the residue was re soaked in 1500mls of 96% ethanol and the procedure followed to attain the ethanol extract was 
similar to that of the ether extraction. The ethanol and ether filtrates were evaporated using a rotary evaporator (Sigma-
Aldrich, USA) to recover the solvents and semi dry ether and ethanol extracts. The semi dry extracts were kept at room 
temperature (25
0
C) for one week to allow complete evaporation of the solvents. The dried ether and ethanol extracts were 
mixed in equal proportions to obtain the total crude extract. The total crude extract stock solution was prepared by 
dissolving 1000mg of the extracts into 5mls of a mixture of olive oil and normal saline in equal volumes. 
 
Experimental design 
 
Twenty four (24) healthy adult mice of either sex, weighing an average of 180±22.2g were purchased from the 
small animal breeding house at the College of Veterinary Medicine, Animal Resources and Biosecurity, Makerere 
University. Mice were randomly assigned into four (4) groups with six animals per group. Animals were treated daily for 
29 days by gastric lavage as shown in Table 1. Group one was the positive control and received 20mg/kg of levamisole 
(Norbrook, Uk) in normal saline and olive oil mixture.  Group two was the negative control and received 2mls of normal 
saline and olive oil mixture. Groups 3 and 4 were the extract treatment groups and received 100 and 200mg/kg bwt of the 
total crude extract respectively. On the 15
th
day, whole blood was collected by puncturing the retro orbital vein of the mice 
for complete blood count determination. For the haemagglutination experiment, blood was collected on the 29
th
 day. 
 
Table 1: Treatments administered to the different groups 
Groups N Treatment (Daily for 29 days) 
Group 1 (Positive control) 6 20 mg/kg of levamisole 
Group 2 (Negative control) 6 2 ml of normal saline and olive oil mixture 
Group 3  6 100 mg/kg of plant extract 
Group 4  6 200 mg/kg of plant extract 
N: number of animals per group. 
98 
 
 
Preparation of sheep red blood cells as antigens 
 
Fresh blood was collected from a sheep in a sterile bottle containing Alsver’s solution (2% dextrose, 0.8% sodium 
citrate, 0.05% citric acid and 0.42% sodium chloride). The sheep red blood cells were washed in normal saline three times 
by centrifugation at 1500 rpm for 5 minutes. The supernatant was discarded and the SRBCs washed again in sterilized 
phosphate buffer saline (pH 7.2). Using a Neubauer counter, SRBCs were enumerated and stored at 4
o
C for use within 4-6 
hours. 
 
Haemagglutination antibody (HA) titer determination 
 
Haemagglutination antibody titer determination was done as previously described (Puri et al., 2000). Four groups 
of animals were used as per treatment groups in a Table 1. All animals were   immunized with 0.1mls of SRBCs suspension 
containing 5×10
9 
cells intraperitoneally on day 0 (day 15). All animals continued to receive their respective treatments for 
more 14 days. Blood samples were collected from each animal by retro-orbital puncture on day 14 (after immunization) 
into clean clot activated vacutainers. After clotting, the blood was centrifuged at 1500 rpm for 5 minutes to obtain serum. 
Two fold dilution of the serum were made using normal saline. To 0.025mls of serum in the micro titer plates, 0.025mls of 
1% (v/v) SRBCs were added and the mixture incubated for 1hr at 37
0
C. The titer plates were then observed for 
haemagglutination. The highest dilution giving haemagglutination was taken as the antibody titer and expressed in a graded 
manner with the minimum dilution (1/2) being ranked as 2. 
 
Determination of the complete blood count (CBC) 
 
On day 15, whole blood from all the animals was collected by retro orbital puncture and placed into clean EDTA 
vacutainers. The CBC was determined using the automated hematological Coulter CBC-5 Hematology analyzer (Beckman 
Coulter, China) using standard procedure at the clinical chemistry laboratory of Mulago hospital. Whole blood (1ml) from 
an EDTA vacutainer was sucked into the machine which was then set to automatically analyze the sample. After five 
minutes, the number and types of the different cells within the blood were displayed by the machine. These were printed 
out and a copy sent to the laboratory computer for easy retrieval whenever required. 
 
Determination of the delayed type hypersensitivity (DTH) response 
 
This was a cell mediated response. The study was conducted using standard methods by Gray et al. (2012). The 
mice were divided into 4 groups each comprising of 6 mice as per the treatment groups above (Table 1). On the 14
th
 day of 
treatment, mice were challenged by sub cutaneous administration of 20µl of 5×10
9 
SRBC per ml into the hind right foot 
pad. The foot thickness was measured using a vernier caliper at 0 hrs (before challenging), 12, 24 and 48hrs after the 
challenge. The differences obtained for pre and post challenge thicknesses were taken as the measurement of DTH and 
expressed in mm.  
 
Ethical consideration 
 
This study was approved by the Institutional Review Board (IRB) at the College Of Veterinary Medicine, Animal 
Resources and Biosecurity. The experimental animals used in this study were treated following international standard 
guidelines on laboratory animal handling (OECD, 1996). Mice were maintained in a controlled environment under standard 
conditions of temperature (28 ± 2˚C) and humidity with an alternating dark and light cycle for a period of one week to 
enable them acclimatize. The mice were fed on commercially available pelleted mice food (Nuvita, Uganda) with water 
provided ad libitum.  
 
Data management and analysis 
 
The data collected for each study was entered in excel spread sheet and later transferred to Graph pad 6.0 
statistical software for subsequent analysis. The data for each group was expressed as mean ± SEM. Effect of the treatment 
on the different parameters was analyzed using a one way ANOVA. Multiple comparisons between groups were done using 
Tukey multiple comparison test set at a significance level α˂ 0.05.  
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Results  
Haemagglutination antibody (HA) titer 
 
 Antibody titer response to sheep red blood cells was measured as an indicator of the humoral immune response. 
Results from the study showed that the treatment had a significant effect (P=0.0003, F (3, 9) =1.75) on the haemagglutination 
titers. Comparison between groups indicated that haemagglutination titers were significantly higher (P=0.003) in the plant 
extract at 200mg/kg (30.67±1.33) group when compared to the negative control (4.00±2.31), positive control (17.33±1.33) 
and the extract group at 100mg/kg (8.00±4.62) (Fig 1).  
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Figure 1:  Effect of treatment on haemagglutination antibody titers. Group 1- positive control; Group 2- negative control; 
Group 3-extract group at 100mg/kg; Group 4-extract group at 200mg/kg. Letters above bars indicate significant differences 
across groups. 
 
Complete blood count (CBC) 
 The complete blood count was carried out to determine the effect of the plant extract on the hematopoietic system. 
The results revealed that the treatment group had a significant effect on the mean WBC count (P=0.038). Comparison 
between groups revealed that WBC counts were significantly higher in the positive control (3.30±1.04×10
3
/µl) and extract 
at 200mg/kg (3.13±0.71×10
3
/µl) groups, when compared to the negative control (1.45±0.55×10
3
/µl) and extract at 
100mg/kg (2.80±0.60×10
3
/µl) (Table 2). The neutrophil and lymphocyte levels in the extract group at 200mg/kg were 
higher than those in both plant extract group at 100mg/kg and the negative control group but comparable to the positive 
control. When other differential WBC counts were compared, no significant differences (P>0.05) were observed.  
 When mean RBC counts were compared, the results revealed that counts were elevated to comparable levels in the 
positive control (8.18±0.97×10
6
/µl), extract at 100mg/kg (8.29±1.10×10
6
/µl) and extract at 200mg/kg (9.54±0.61×10
6
/µl) 
groups. The HCT count was significantly higher in the extract group at 200mg/kg (40.40±3.29 pg) than in both the positive 
control (34.10±4.57pg) and extract at 100mg/kg (34.57±5.51 pg) groups which were comparable. When RDW-CV and 
PDW counts were compared, the extract groups at 200mg/kg remained significantly comparable to the positive control 
group (Table 3).  
 
Table 2: Effect of treatment on white blood cell counts 
Treatment Mean WBC 
(×10
3
/µl)  
Differential WBC counts (cells/µl) 
           NE            LY       MO             EO             BA 
Levamisole (20mg/kg) 3.30±1.04
a 
1.05±0.48
a 
2.30±0.11
a 
0.15±0.06
a 
1.08±o.43
a 
0.08±0.03
a 
Oil and normal saline (2ml)  1.45±0.55
b 
0.73±0.20
b 
1.10±1.13
b 
0.10±0.06
a 
0.53±0.25
a 
0.03±0.03
a 
Plant extract (100mg/kg)  2.80±0.60
b 
0.09±0.44
b 
0.63±0.58
b 
0.07±0.07
a 
1.25±0.75
a 
0.03±0.03
a 
Plant extract (200mg/kg) 3.13±0.71
a 
0.93±0.48
a 
2.20±0.00
a 
0.17±0.09
a 
2.40±0.30
a 
0.00±0.00
a 
       
Lower case letters indicate significant differences across groups. WBC: white blood cell, NE: neutrophil, MO: monocytes, 
LY: lymphocytes, EO: eosinophils, BA: basophils 
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Table 3: Effect of treatment on red blood cell counts 
Treatment Mean 
RBCS×10
6
/µl  
Blood cell Indices 
           HCT MCH(pg)              RDW-CV (%) PDW (%) 
Levamisole (20mg/kg) 8.18±0.97
a 
34.10±4.57
b 
18.13±2.16
a 
15.80±0.76
a 
14.25±0.69
a 
Oil and normal saline (2ml) 6.81±2.09
b 
26.83±7.67
c 
14.93±0.28
b 
11.63±2.96
b 
10.75±3.59
b 
Plant extract (100mg/kg) 8.29±1.10
a 
34.57±5.51
b 
15.90±0.70
b 
13.73±0.33
b 
16.07±0.52
a 
Plant extract (200mg/kg) 9.54±0.61
a 
40.40±3.29
a 
15.10±0.72
b 
14.53±0.46
a 
16.30±0.15
a 
      
Lower case letters indicate significant differences across treatment groups. HCT: haematocrit, MCH: mean corpuscular 
haemoglobin, RDW-CV: red cell distribution width-corpuscular volume, PDW: platelet distribution width 
 
Delayed type hypersensitivity (DTH) response 
 
The delayed type hypersensitivity response was measured using foot pad thickness following injection with sheep 
red blood cells. No significant differences in footpad thickness were observed between the extract groups and the negative 
control (P>0.05) even after 24 hours, indicating that the extract did not have a significant impact on footpad thickness 
(Table 4). However, the positive control group had significantly higher (0.14±0.09mm) mean footpad thickness compared 
to other groups at 24 hours.  
 
Table 4: Effect of treatment on delayed type hypersensitivity response 
Treatment groups Mean difference in  footpad thickness± SEM (mm) 
          12hrs         24hrs          48hrs 
Levamisole (20mgkg) 0.14±0.09
a 
0.14±0.09
a 
0.01±0.04
a 
normal saline (2ml) 0.01±0.01
a 
0.01±0.01
b 
0.04±0.04
a 
Plant extract (100mg/kg) 0.08±0.05
a 
0.08±0.05
b 
0.04±0.02
a 
Plant extract (200mg/kg) 0.08±0.03
a 
0.08±0.03
b 
0.01±0.04
a 
    
Lower case letters indicate significant differences across treatment groups 
 
Discussion 
  
Medicinal plants used for immunostimulation provide potential alternatives to conventional chemotherapeutics for 
a variety of diseases to overcome undesirable drug effects (Diwanay et al., 2004). A number of plant derivatives such as 
polysaccharides, lectins, peptides, flavonoids and tannins have been reported to modulate the immune system (Hilla et al., 
2004; Venkatachalam et al., 2009). Similarly, such immunomodulatory derivatives have been reported in the genus 
Chenopodium (Kokanova-Nedialkova et al., 2009). In Uganda, Chenopodium opulifolium is claimed to boost the immune 
system albeit with no scientific evidence to back these claims. We therefore investigated the immunomodulatory activity of 
the total crude leaf and stem extract of Chenopodium opulifolium in mice.  
The results showed that the total crude extract of Chenopodium opulifolium had a significant effect on 
haemagglutination antibody titers. Higher antibody titers were observed in the extract group at 200mg/kg even when 
compared with the positive control. This was in agreement with studies by Suseelan et al. (2001) who reported that a 
purified haemagglutinin molecule isolated from Chenopodium amaranticolor showed haemagglutination activity in rabbit 
erythrocytes at pH between 3 and 12. Similarly, a study by Woldemichael et al. (2001) reported that saponins 
(monodesmosides) isolated from the seeds of Chenopodium quinoa showed hemolytic activity on erythrocytes. Indeed, 
studies on plant extracts from different genus showed haemagglutination activity; Ross et al. (2001) on Punica granutum L. 
fruit rind powder in rabbits, Makare et al. (2001) on the ethanolic extract of Mangifera indica L. stem bark in mice and 
Gautam et al. (2009) on the aqueous extract of Asparagus racemosus root. Probably, the reason for higher 
haemagglutination titers was due to the presence of saponins (Kokanova-Nedialkova et al., 2009) and haemagglutinin 
molecules as previously reported (Suseelan et al., 2001).  
In this study, the mean WBC, Neutrophil and Lymphocyte counts in the 200mg/kg bwt extract group were 
elevated to levels comparable to the positive control. Indeed, in a study by Mousavi et al. (2008) it was demonstrated that 
Chenopodium album extract increased IFN-γ and IL-10 productions in a murine asthma model.  
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Furthermore, Rios et al. (2017) showed that the crude extract of Chenopodium ambrosioides was stimulatory to 
murine but not human lymphocytes. Studies using other plant extracts have reported elevated WBC counts. Among these 
are; a study by Lubega et al. (2013) on the total crude extract of Hibiscus sadbariffa and another study by Gautam et al. 
(2009) on Asparagus racemosus. This elevation in WBC, neutrophils, lymphocytes and RBCs is probably attributed to the 
presence of vitamin D3 that has been shown to have hematopoietic activity (Danilenko et al., 2004). 
In this study, the extract did not have any significant effect on DTH as measured by foot pad thickness even after 
48 hours. A significant elevation in foot pad thickness was only noticeable for the positive control after 24 hours. We did 
not find any published data comparing DTH response in Chenopodium genus. However, in other plant extracts DTH has 
been demonstrated.  A study by Lubega et al. (2013) showed that the total crude extract of Hibiscus sabdariffa at a dose of 
500mg/kg bwt caused a 175.2% increment in foot pad thickness after 12 hrs in Wistar albino rats. Another study by 
Gaikwad et al. (2011) showed that the Moringa oleifera leaf extract stimulated DTH in Wistar albino rats after 24 hrs. A 
study by Gautam et al. (2009) reported that the Asparagus racemosus plant extract had an incremental effect on DTH 
response in mice while another by Makare et al. (2001), showed that the alcoholic extract of Mangifera indica L. produced 
an increase in DTH response in mice. We could not find a plausible explanation as to why the extract did not elicit a 
noticeable DTH. 
 
Conclusion  
 
The total crude extract of Chenopodium opulifolium exhibits immunomodulatory activity in a dose dependent 
manner. Future studies utilizing pure extracts in order to pin point the exact mechanism responsible for Immunomodulation 
are required for more conclusive results. 
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